汉族人群阻塞性睡眠呼吸暂停全基因组关联研究识别新风险位点
该研究在20,590名汉族个体(5,438例OSA和15,152例对照)中开展全基因组关联研究,识别出两个OSA特征性显著位点:PACRG内含子变异rs6455893和SLC52A3错义变异rs3746804,并发现18个与定量OSA及客观睡眠相关性状相关的全基因组显著位点。功能实验提示rs3746804可能促进核黄素摄取。
要点
- PACRG rs6455893与OSA风险升高相关(OR=1.62)。
- SLC52A3 rs3746804与OSA风险降低相关(OR=0.83)。
- SLC52A3可能为治疗靶点,核黄素可能为治疗剂。
核心结论
- 识别出多个与OSA及客观睡眠相关性状相关的全基因组显著位点。
- SLC52A3可能为治疗靶点,核黄素可能为治疗剂。
研究设计与样本
- 在20,590名汉族个体(5,438例OSA和15,152例对照)中开展全基因组关联研究。
- 使用人类样本和点突变敲入小鼠进行后续基因功能研究。
主要发现
- PACRG内含子变异rs6455893与OSA相关(OR=1.62;95%CI 1.39-1.89;P=6.98×10-10)。
- SLC52A3错义变异rs3746804与OSA相关(OR=0.83;95%CI 0.79-0.88;P=7.57×10-10)。
- 识别出18个与定量OSA及客观睡眠相关性状相关的全基因组显著位点,其中5个超过研究-wide显著性阈值。
- rs3746804与血清核黄素浓度升高相关,小鼠相应突变增加核黄素浓度。
临床怎么用
- SLC52A3 rs3746804可能作为OSA风险分层或治疗靶点的候选标志物。
- 核黄素可能成为OSA的潜在治疗剂,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Previous genetic studies of obstructive sleep apnea (OSA) have limitations in terms of precise case definition, integrated quantitative traits, and interpretation of genetic functions; thus, the heritability of OSA remains poorly explained. Objectives: To identify novel genetic variants associated with OSA and objective sleep-related traits and to explore their functional roles. Methods: A genome-wide association study was performed in 20,590 Han Chinese individuals (5,438 OSA and 15,152 control samples). Human samples and point mutation knockin mice were used for follow-up investigation of gene functions. Measurements and Main Results: Two characteristic study-wide significant loci (P < 2.63 × 10-9) for OSA were identified: the PACRG intronic variant rs6455893 on 6q26 (odds ratio [OR] = 1.62; 95% confidence interval [CI], 1.39-1.89; P = 6.98 × 10-10) and the missense variant rs3746804 (p.Pro267Leu) in the riboflavin transporter SLC52A3 on 20p13 (OR = 0.83; 95% CI, 0.79-0.88; P = 7.57 × 10-10). In addition, 18 genome-wide significant loci associated with quantitative OSA and objective sleep-related traits were identified, 5 of which exceeded the study-wide significance threshold. Rs3746804 was associated with elevated serum riboflavin concentrations, and the corresponding mutation in mice increased riboflavin concentrations, suggesting that this variant may facilitate riboflavin uptake and riboflavin-dependent physiological activity. Conclusions: We identified several novel genome-wide significant loci associated with OSA and objective sleep-related traits. Our findings provide insight into the genetic architecture of OSA and suggest that SLC52A3 might be a therapeutic target, whereas riboflavin might be a therapeutic agent.
引用
- Xu H, Liu F, Li Z, et al. Genome-Wide Association Study of Obstructive Sleep Apnea and Objective Sleep-related Traits Identifies Novel Risk Loci in Han Chinese Individuals. Am J Respir Crit Care Med. 2022. PMID: 35819321. doi:10.1164/rccm.202109-2044OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。